STAND Against Emerging Opioids Act

Hozzl · 2025-06-13T08:06:17Z

Explore the details of House Bill 3520 STAND Against Emerging Opioids Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Crime and Law Enforcement. Stay informed on legislative developments.

6/13/2025, 8:06 AM

Summary of Bill HR 3520

This bill, designated as H.R. 3520 in the 119th Congress, aims to amend the Controlled Substances Act to classify tianeptine as a schedule III substance. The bill, introduced on May 20, 2025, includes provisions related to the scheduling of tianeptine and may contain additional directives or purposes outlined in the official PDF version linked to the bill.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 3520

Bill HR 3520 is currently in the status of Bill Introduced since May 20, 2025. Bill HR 3520 was introduced during Congress 119 and was introduced to the House on May 20, 2025. Bill HR 3520's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of May 20, 2025